Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)
Pfeifer H. et al, (2020), Leukemia, 34
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology
Patel B. et al, (2014), Blood, 124, 96 - 105
Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist?
Nacheva EP. et al, (2013), British Journal of Haematology, 161, 541 - 550
Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function
Zhang Y. et al, (2012), Journal of Immunology, 188, 1002 - 1010
Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights
Patel B. et al, (2011), Molecular Therapy, 19, 1034 - 1040
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell‐origin of ALL subgroups – a UKALLXII study
Rai L. et al, (2010), British Journal of Haematology, 148, 394 - 401
Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
Patel B. et al, (2010), British Journal of Haematology, 148, 80 - 89